{"id":"https://openalex.org/W2554055446","doi":"https://doi.org/10.1182/blood.v112.11.1420.1420","title":"Deferasirox (Exjade\u00ae), the Once-Daily Oral Iron Chelator, Demonstrates Safety and Efficacy in Patients with Sickle Cell Disease (SCD): 3.5-Year Follow-up.","display_name":"Deferasirox (Exjade\u00ae), the Once-Daily Oral Iron Chelator, Demonstrates Safety and Efficacy in Patients with Sickle Cell Disease (SCD): 3.5-Year Follow-up.","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2554055446","doi":"https://doi.org/10.1182/blood.v112.11.1420.1420","mag":"2554055446"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.1420.1420","doi":"https://doi.org/10.1182/blood.v112.11.1420.1420","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.1420.1420","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056946591","display_name":"Elliott P. Vichinsky","orcid":"https://orcid.org/0000-0002-0500-9579","observed_orcids":["https://orcid.org/0000-0002-0500-9579"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elliott Vichinsky","raw_affiliation_strings":["Children\u2019s Hospital and Research Center Oakland, Oakland, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Hospital and Research Center Oakland, Oakland, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077729374","display_name":"Thomas D. Coates","orcid":"https://orcid.org/0000-0001-9878-6029","observed_orcids":["https://orcid.org/0000-0001-9878-6029"]},"institutions":[{"id":"https://openalex.org/I1336910626","display_name":"Children's Hospital Los Angeles","ror":"https://ror.org/00412ts95","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1336910626"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Coates","raw_affiliation_strings":["Children\u2019s Hospital Los Angeles, Los Angeles, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Hospital Los Angeles, Los Angeles, CA, USA","institution_ids":["https://openalex.org/I1336910626"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038535078","display_name":"Alexis A. Thompson","orcid":"https://orcid.org/0000-0003-4961-8103","observed_orcids":["https://orcid.org/0000-0003-4961-8103"]},"institutions":[{"id":"https://openalex.org/I1294278766","display_name":"Lurie Children's Hospital","ror":"https://ror.org/03a6zw892","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1294278766"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alexis A Thompson","raw_affiliation_strings":["Children\u2019s Memorial Hospital, Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Memorial Hospital, Chicago, IL, USA","institution_ids":["https://openalex.org/I1294278766"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033760104","display_name":"Fran\u00e7oise Bernaudin","orcid":"https://orcid.org/0000-0001-5184-8288","observed_orcids":["https://orcid.org/0000-0001-5184-8288"]},"institutions":[{"id":"https://openalex.org/I4210159273","display_name":"H\u00f4pital Intercommunal de Cr\u00e9teil","ror":"https://ror.org/04n1nkp35","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210159273"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Franc\u0327oise Bernaudin","raw_affiliation_strings":["Centre Hospitalier Intercommunal, Cre\u0301teil, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Intercommunal, Cre\u0301teil, France","institution_ids":["https://openalex.org/I4210159273"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064485043","display_name":"Martha Rodriguez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Martha Rodriguez","raw_affiliation_strings":["Novartis, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis, East Hanover, NJ, USA","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040695566","display_name":"Lisa Payne Rojkjaer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283582996","display_name":"Novartis (Switzerland)","ror":"https://ror.org/02f9zrr09","country_code":"CH","type":"company","lineage":["https://openalex.org/I1283582996"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"Lisa Rojkjaer","raw_affiliation_strings":["Novartis, Basel, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis, Basel, Switzerland","institution_ids":["https://openalex.org/I1283582996"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077501925","display_name":"Matthew M. Heeney","orcid":"https://orcid.org/0000-0002-1104-6843","observed_orcids":["https://orcid.org/0000-0002-1104-6843"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew M Heeney","raw_affiliation_strings":["Children\u2019s Hospital Boston, Boston, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children\u2019s Hospital Boston, Boston, MA, USA","institution_ids":["https://openalex.org/I1288882113"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":6,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":1.0711,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.78943487,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"112","issue":"11","first_page":"1420","last_page":"1420"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10554","display_name":"Hemoglobinopathies and Related Disorders","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10452","display_name":"Iron Metabolism and Disorders","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10693","display_name":"Blood transfusion and management","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2704","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/deferasirox","display_name":"deferasirox","score":0.996999979019165},{"id":"https://openalex.org/keywords/sickle-cell-disease","display_name":"sickle cell disease","score":0.9490000009536743},{"id":"https://openalex.org/keywords/iron-chelation-therapy","display_name":"iron chelation therapy","score":0.8090000152587891},{"id":"https://openalex.org/keywords/transfusional-iron-overload","display_name":"transfusional iron overload","score":0.9629999995231628},{"id":"https://openalex.org/keywords/secondary-iron-overload","display_name":"secondary iron overload","score":0.7149999737739563},{"id":"https://openalex.org/keywords/liver-iron-concentration","display_name":"liver iron concentration","score":0.734000027179718},{"id":"https://openalex.org/keywords/serum-ferritin","display_name":"serum ferritin","score":0.828000009059906},{"id":"https://openalex.org/keywords/renal-function","display_name":"renal function","score":0.5860000252723694},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.5960000157356262},{"id":"https://openalex.org/keywords/long-term-safety","display_name":"long-term safety","score":0.6539999842643738},{"id":"https://openalex.org/keywords/pediatric-patients","display_name":"pediatric patients","score":0.6290000081062317},{"id":"https://openalex.org/keywords/adult-patients","display_name":"adult patients","score":0.5920000076293945},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.5379999876022339},{"id":"https://openalex.org/keywords/long-term-follow-up","display_name":"long-term follow-up","score":0.5260000228881836},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.5249999761581421},{"id":"https://openalex.org/keywords/liver-transplantation","display_name":"liver transplantation","score":0.453000009059906},{"id":"https://openalex.org/keywords/iron-intake","display_name":"iron intake","score":0.41999998688697815}],"concepts":[{"id":"https://openalex.org/C2781053155","wikidata":"https://www.wikidata.org/wiki/Q5251502","display_name":"Deferasirox","level":3,"score":0.9952220916748047},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8538990616798401},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6060675382614136},{"id":"https://openalex.org/C2777218474","wikidata":"https://www.wikidata.org/wiki/Q1069061","display_name":"Chelation therapy","level":3,"score":0.5979688167572021},{"id":"https://openalex.org/C2776672577","wikidata":"https://www.wikidata.org/wiki/Q419618","display_name":"Deferoxamine","level":2,"score":0.5884956121444702},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.552386462688446},{"id":"https://openalex.org/C159641895","wikidata":"https://www.wikidata.org/wiki/Q108377937","display_name":"Renal function","level":2,"score":0.5050252079963684},{"id":"https://openalex.org/C2778248108","wikidata":"https://www.wikidata.org/wiki/Q5445","display_name":"Anemia","level":2,"score":0.46188870072364807},{"id":"https://openalex.org/C2777799968","wikidata":"https://www.wikidata.org/wiki/Q185137","display_name":"Thalassemia","level":2,"score":0.4583662152290344},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.437042236328125},{"id":"https://openalex.org/C2780817109","wikidata":"https://www.wikidata.org/wiki/Q954625","display_name":"Myelodysplastic syndromes","level":3,"score":0.43618106842041016},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3563169538974762},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v112.11.1420.1420","doi":"https://doi.org/10.1182/blood.v112.11.1420.1420","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.1420.1420","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2559580547","https://openalex.org/W1911216300","https://openalex.org/W1747646164","https://openalex.org/W190357846","https://openalex.org/W2553536515","https://openalex.org/W4255257391","https://openalex.org/W2594652814","https://openalex.org/W2587074188","https://openalex.org/W2969787472","https://openalex.org/W2035594167"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Many":[2],"patients":[3,31,56,95,100,138,197,268,298],"with":[4,32,57,59,64,88,96,130,400],"SCD":[5,33,58,94,401],"require":[6],"chronic":[7],"transfusion":[8],"therapy":[9],"to":[10,71,156,169,200,213,239,242,334,418],"manage":[11],"the":[12,153,237,243,285],"complications":[13],"of":[14,143,167,180,288,323,430],"their":[15,413],"disease":[16],"(eg":[17],"stroke":[18],"prevention);":[19],"as":[20],"a":[21,68,72,102,177],"consequence,":[22],"secondary":[23],"iron":[24,36,61,84,97,186,404,415],"overload":[25,62,405],"may":[26],"develop.":[27],"Controlled":[28],"data":[29,49],"from":[30,326],"receiving":[34,406],"long-term":[35,407],"chelation":[37],"therapy,":[38],"particularly":[39],"renal":[40,132,432],"function,":[41],"are":[42,50,159],"lacking.":[43],"Cumulative":[44],"3.5-year":[45],"safety":[46,121],"and":[47,54,90,106,120,126,220,262,283,378,390,402],"efficacy":[48],"presented":[51],"for":[52,204],"adult":[53],"pediatric":[55],"transfusional":[60,403],"treated":[63],"deferasirox":[65,89,108,158,170,324,384,396,408],"(Exjade\u00ae)":[66],"in":[67,93,152,161,274,303,317,381,393,412,425],"4-year":[69,103],"extension":[70,104],"1-year":[73],"comparative":[74],"study":[75,155,244],"(109).":[76],"Methods:":[77],"Study":[78],"109":[79],"demonstrated":[80,409],"similar":[81],"dose-dependent":[82,370],"liver":[83],"concentration":[85],"(LIC)":[86],"reductions":[87],"deferoxamine":[91],"(DFO)":[92],"overload.":[98],"Eligible":[99],"entered":[101],"phase":[105],"received":[107],"only;":[109],"dose":[110,179,322,377,389],"adjustments":[111],"were":[112,134,149,252,278,293,314,369],"based":[113],"on":[114,307],"monthly":[115],"serum":[116,275],"ferritin":[117],"(SF)":[118],"levels":[119,313],"assessments":[122],"(adverse":[123],"events":[124],"[AEs]":[125],"laboratory":[127],"parameters).":[128],"Patients":[129,399],"abnormal":[131],"function":[133],"excluded.":[135],"Results:":[136],"132":[137],"(mean":[139],"age":[140],"\u00b1":[141,145,182,193,328,336],"SD":[142],"19.1":[144],"10.7":[146],"years)":[147,175],"who":[148],"initially":[150],"randomized":[151],"core":[154],"receive":[157,201],"included":[160],"this":[162,189],"analysis.":[163],"The":[164,246],"median":[165,344,379,391],"duration":[166],"exposure":[168],"was":[171,191,225,233,347],"37.4":[172],"months":[173],"(3.1":[174],"at":[176,308,331,339],"mean":[178],"18.4":[181],"6.2":[183],"mg/kg/day.":[184,195],"Mean":[185,320,376,388],"intake":[187],"over":[188],"period":[190],"0.3":[192],"0.1":[194],"72":[196],"(54.5%)":[198],"continue":[199],"deferasirox.":[202],"Reasons":[203],"discontinuations":[205],"include:":[206],"AEs":[207,251],"(n=11),":[208],"consent":[209],"withdrawal":[210],"(n=24),":[211],"lost":[212],"follow-up":[214],"(n=9),":[215],"unsatisfactory":[216],"therapeutic":[217],"effect":[218],"(n=4),":[219],"other":[221],"reasons":[222],"(n=11).":[223],"There":[224],"also":[226],"one":[227,310],"death":[228],"reported":[229],"post-liver":[230],"transplantation,":[231],"which":[232,351],"not":[234,372],"considered":[235],"by":[236,353,362],"investigator":[238],"be":[240],"related":[241],"drug.":[245],"most":[247],"frequent":[248],"drug-related":[249],"(investigator-assessed)":[250],"nausea":[253],"(n=20;":[254],"15.2%),":[255],"diarrhea":[256],"(n=14;":[257],"10.6%),":[258],"vomiting":[259],"(n=8;":[260],"6.1%)":[261],"abdominal":[263],"pain":[264],"(n=6;":[265],"4.5%).":[266],"Nine":[267],"(6.8%)":[269],"had":[270,300],"two":[271,318],"consecutive":[272],"increases":[273],"creatinine":[276],"that":[277],"both":[279],">33%":[280],"above":[281,284],"baseline":[282,312,343],"upper":[286],"limit":[287],"normal":[289],"(ULN);":[290],"however,":[291],"there":[292],"no":[294],"progressive":[295,431],"increases.":[296],"Five":[297],"(3.8%)":[299],"an":[301,422],"increase":[302,424],"alanine":[304],"aminotransferase":[305],">10xULN":[306],"least":[309],"visit;":[311],"already":[315],">ULN":[316],"patients.":[319],"daily":[321],"increased":[325],"15.4":[327],"6.9":[329],"mg/kg/day":[330,338],"month":[332,340,363],"1":[333],"22.3":[335],"7.3":[337],"42.":[341],"Overall":[342],"SF":[345,367,382,394,419],"level":[346],"3439":[348],"ng/mL":[349,355],"(n=132),":[350],"decreased":[352],"651":[354],"(P=0.0533,":[356],"Wilcoxon":[357],"signed":[358],"rank":[359],"test;":[360],"n=49)":[361],"42":[364],"(Figure":[365],"1).":[366],"decreases":[368],"(data":[371],"shown).":[373],"Figure":[374,386],"1.":[375,387],"change":[380,392],"during":[383,395],"treatment":[385,397],"Conclusions:":[398],"continued":[410],"reduction":[411],"body":[414],"burden":[416],"(according":[417],"levels),":[420],"without":[421],"exposure-associated":[423],"AE":[426],"incidence,":[427],"or":[428],"evidence":[429],"dysfunction.":[433]},"counts_by_year":[{"year":2023,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-22T18:32:59.640997","created_date":"2016-11-30T00:00:00"}